[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100443425":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":28,"responsibleParty":46,"collaborators":11,"id":48,"slug":11,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":11,"enrollmentInfo":56,"targetDuration":11,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":68,"whyStopped":11,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Institut Paoli-Calmettes","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient treated with CAR-T cells","EXPERIMENTAL",null,[13],"Other: Blood sample collection",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Blood sample collection","Blood samples collection: at Day (D)-6 and D0 before CAR-T cells injection, post injection at Day (D)3, D5,D7, D9, D11, D14, D18, D 21, Month 2 and Month 12 post injection.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Dominique GENRE, MD","CONTACT","+33491223778","drci.up@ipc.unicancer.fr",{"name":26,"role":22,"phone":23,"phoneExt":11,"email":27},"Jihane PAKRADOUNI, Pharm PhD","pakradounij@ipc.unicancer.fr",[29],{"facility":5,"status":11,"city":30,"state":11,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Marseille","13273","France",{"type":34,"coordinates":35},"Point",[36,37],5.38107,43.29695,{"lat":37,"lon":36},[40,43],{"name":41,"role":22,"phone":42,"phoneExt":11,"email":24},"GENRE Dominique, MD","33(0) 4 91 22 37 78",{"name":44,"role":45,"phone":11,"phoneExt":11,"email":11},"Claude Lemarié, PharmD","PRINCIPAL_INVESTIGATOR",{"type":47,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100443425",false,"NCT05054231","Immunological Profile for Patients Treated With CAR-T Cells","SI-CART","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Planned injection of CAR-T cells within the scope of marketing authorization\n* Signed informed consent\n* French social security affiliation\n\nExclusion Criteria:\n\n* Pregnant women, or women of childbearing potential (without medically acceptable contraception) or breastfeeding women.\n* Patient in emergency situation, adult under legal protection (patient placed under tutorship, curatorship, or judicial protection) or unable to give his consent\n* Impossibility to comply with trial medical follow-up for geographic, social or psychological reasons","ALL","18 Years",{"count":57,"type":58},500,"ESTIMATED","INTERVENTIONAL",[61],"NA","In the frame of Si-CART study, blood will be collected from patients treated with CAR-T cells: before (at Day (D)-6 and D0 before cells injection), post infusion at D3, D5,D7, D9, D11, D14, D18, D 21, Month (M) 2 and M12 post injection.\n\nA cerebrospinal fluid sample will also be collected if a Cerebrospinal Fluid Analysis Lumbar puncture is performed",[64],"Hematologic Neoplasms",[66,67],"CAR-T cells","Immunological Profile","NOT_YET_RECRUITING","2021-10-07",{"date":71,"type":72},"2021-10-15","ACTUAL",{"date":74,"type":58},"2021-10-05",{"date":76,"type":58},"2026-10-05",{"name":5,"class":6},1]